Benjamin Toll

Dr. Benjamin Toll is a Professor, Adjunct in the Department of Psychiatry at Yale School of Medicine. He specializes in clinical research on tobacco and alcohol use disorders, focusing on smoking cessation interventions and health behavior improvement. His research includes clinical trials on novel treatments, such as gain-framed messaging and pharmacological interventions like varenicline. He holds leadership roles in organizations like the Society for Research on Nicotine and Tobacco (SRNT) and American Association for Cancer Research (AACR).

Education:

• PhD in Clinical Psychology, Nova Southeastern University (2002)
• MS in Clinical Psychology, Nova Southeastern University (1999)
• BA in Psychology, Cornell University (1996)

Research Interests: Development of psychosocial and pharmacological treatments for tobacco dependence, message framing for smoking cessation, and measurement of tobacco-related syndromes. Current projects include studies on naltrexone for weight management post-cessation and digital cessation tools for older adults.

Grants & Funding: Multiple NIH/NCI R01 grants, including support for clinical trials and tobacco control initiatives. Collaborates with institutions like the New York State Smokers' Quitline and the Smoking Cessation and Alcohol Treatment Research Clinic at Yale.

Labs & Affiliations: Leads the Smoking Cessation Service at Smilow Cancer Hospital and is affiliated with the Yale Cancer Center and Women's Health Research at Yale.